Thursday, July 17, 2025 12:14:20 AM
It was.
You need to check some facts before you start throwing failure around.
Kbl started the hybrid project in 2023.
They created 9 new strains, by the end of 2023 kbl narrowed it down to 6.
At the same time only 1 strain was homozygous for the spider silk transgene.
On February 6th 2024 kbl announced the creation of bam 1.
Homozygosity with the second parental strain of bam1 had still not been achieved.
February 27 they announced
Establishes Homozygosity and Confirms BAM 1 Hybrid Ready for Spring Production Trial.
You can't start with something that isn't ready.
It takes longer to develop a diapause transgenic than a non-diapause.
Kbl did what people wanted.
They used the quickest strains to develop bam 1 so they could produce spidersilk now instead of waiting for the perfect hybrid.
Kbl has finally reached the point where Dr Speers said in December
I’m even more excited for the many new hybrids we expect
to introduce over the next 12 months
From june 3 2025
The development of a new spider silk production transgenic has been a key part of our production roadmap since 2023 and a primary objective of our genetics team during the last 18 months. Our longstanding plans were to field a new strain of silkworm for our double hybrid production system in the Summer of 2025. To be frank, we were unsure whether we could meet that ambitious schedule. We were, therefore, ecstatic to announce that we created another world’s first development on schedule. This and many of our other laboratory announcements are not only significant; they’re foundational technology building blocks to our success.
Our current single hybrid system, utilizing BAM-1, has already shown massive improvement in robustness and silk production output. The newly announced strain is another significant improvement in our production, moving us a significant step closer to a more powerful double hybrid. The double hybrid model is designed to significantly improve our silk production rate; we expect by as much as 25+% per month, so this is something that we were very excited to share with our shareholders.
You need to check some facts before you start throwing failure around.
Kbl started the hybrid project in 2023.
They created 9 new strains, by the end of 2023 kbl narrowed it down to 6.
At the same time only 1 strain was homozygous for the spider silk transgene.
On February 6th 2024 kbl announced the creation of bam 1.
Homozygosity with the second parental strain of bam1 had still not been achieved.
February 27 they announced
Establishes Homozygosity and Confirms BAM 1 Hybrid Ready for Spring Production Trial.
You can't start with something that isn't ready.
It takes longer to develop a diapause transgenic than a non-diapause.
Kbl did what people wanted.
They used the quickest strains to develop bam 1 so they could produce spidersilk now instead of waiting for the perfect hybrid.
Kbl has finally reached the point where Dr Speers said in December
I’m even more excited for the many new hybrids we expect
to introduce over the next 12 months
From june 3 2025
The development of a new spider silk production transgenic has been a key part of our production roadmap since 2023 and a primary objective of our genetics team during the last 18 months. Our longstanding plans were to field a new strain of silkworm for our double hybrid production system in the Summer of 2025. To be frank, we were unsure whether we could meet that ambitious schedule. We were, therefore, ecstatic to announce that we created another world’s first development on schedule. This and many of our other laboratory announcements are not only significant; they’re foundational technology building blocks to our success.
Our current single hybrid system, utilizing BAM-1, has already shown massive improvement in robustness and silk production output. The newly announced strain is another significant improvement in our production, moving us a significant step closer to a more powerful double hybrid. The double hybrid model is designed to significantly improve our silk production rate; we expect by as much as 25+% per month, so this is something that we were very excited to share with our shareholders.
Recent KBLB News
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/21/2026 06:41:52 PM
- Kraig Biocraft Laboratories Advances Record Production and Begins Processing 1.8 Metric Tons of Recombinant Spider Silk Cocoons • GlobeNewswire Inc. • 04/20/2026 11:05:00 AM
- The End of Performance at Any Cost, as Spider Silk Points to a Cleaner Future • GlobeNewswire Inc. • 04/15/2026 01:15:00 PM
- Advanced Materials Science 2026: How Spider Silk, Carbon Fiber & Aerogels are Powering Medicine, Defense & Space Tech Today • GlobeNewswire Inc. • 04/14/2026 01:20:00 PM
- From Milestone to Momentum: Kraig Biocraft Leadership Travels to South East Asia Following Record-Setting 1.3 Metric Ton Recombinant Spider Silk Cocoon Production Cycle • GlobeNewswire Inc. • 04/13/2026 11:05:00 AM
- From Genetic Puzzle to Industrial Platform • GlobeNewswire Inc. • 04/08/2026 01:31:34 PM
- Why Advanced Materials Are Reshaping the Industrial Ecosystem • GlobeNewswire Inc. • 04/07/2026 01:15:00 PM
- The intersection of biotechnology, advanced materials, and molecular biology • IH Market News • 04/07/2026 06:56:44 AM
- Spider Silk Has Been a Lab Curiosity for Decades; One Company Just Produced Over a Ton of It in a Single Month • AllPennyStocks.com • 04/06/2026 05:06:15 PM
- Kraig Biocraft Laboratories Shatters Production Record, Delivering Over 1.3 Metric Tons of Spider Silk Cocoons in a Single Month, A 5X Increase Over Previous High • GlobeNewswire Inc. • 04/06/2026 11:05:00 AM
- From Lab Fiber to Luxury Fabric: Kraig Biocraft Laboratories Targets Apparel First with Engineered Spider Silk • GlobeNewswire Inc. • 04/02/2026 01:05:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/30/2026 09:38:14 PM
- Kraig Biocraft Laboratories Deploys Over 700,000 BAM-1 Alpha Production Hybrids, Achieving Key Milestone in its Aggressive Scale-Up Plan • GlobeNewswire Inc. • 03/30/2026 11:05:00 AM
- Kraig Biocraft Laboratories Increases R&D Capacity, as Project Atlas Breakthroughs Creating New Spider Silk Transgenics • GlobeNewswire Inc. • 03/23/2026 11:05:00 AM
- Engineered Silkworms Spin Spider Silk as Biotech Firm Targets Commercial Scale • GlobeNewswire Inc. • 03/18/2026 12:51:04 PM
- 24/7 Market News: Kraig Labs the Bootstrapped Unicorn in the Making • GlobeNewswire Inc. • 03/11/2026 01:15:00 PM
- Washington’s Textile Strategy: How DPA Title III Could Strengthen U.S. Manufacturing and Defense Supply Chains • GlobeNewswire Inc. • 03/05/2026 03:05:00 PM
- Kraig Biocraft Laboratories Targets New Industrial and Defense Biomaterials as "Project Atlas" Hits Major Milestone • GlobeNewswire Inc. • 03/05/2026 12:05:00 PM
- Defense Supply Chains and Strategic Materials Drive the Morning Bid • GlobeNewswire Inc. • 03/03/2026 02:51:45 PM
- Follow-Through Leaders: Production Ramps, AI Alliances, Balance Sheet Strength • GlobeNewswire Inc. • 02/27/2026 02:45:46 PM
- Biotech and Big Tech Drive the Morning Narrative • GlobeNewswire Inc. • 02/24/2026 03:17:14 PM
- 24/7 Market News- “Somewhere in Michigan”: National Geographic Spotlights Kraig Biocraft Laboratories Science Powering Recombinant Spider Silk Production • GlobeNewswire Inc. • 02/24/2026 01:05:00 PM
- Biotech Breakthroughs, Big Buyouts, Immunotherapy Momentum, and a Media Megamerger • GlobeNewswire Inc. • 02/23/2026 02:36:14 PM
- Kraig Biocraft Laboratories’ Spider Silk Advancements Featured as the Cover of National Geographic's March 2026 Issue • GlobeNewswire Inc. • 02/23/2026 12:05:00 PM
- $30M Revenue Rocket, Super Spiders, and Biotech Patent Blitz Launch Morning Momentum • GlobeNewswire Inc. • 02/19/2026 04:00:26 PM
